Contact Us

1.800.553.9910

The articles on our Web site include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice or as an expression of the views of the firm, its attorneys or any of its clients. We hope the articles spur discussion in the legal community with insight into the experience of the authors. We expressly reserve the right in the future to become wiser or simply change our mind.

Dangerous or Defective Drugs or Medical Devices Articles

September 2006	Increased Risk of Blood Clots with Use of Ortho Evra Birth Control Patch New Label Warns Johnson & Johnson’s Ortho Evra birth control patch now comes with a new warning that users could face twice the risks of blood clots in their lungs and legs compared with birth control pills.
July 24, 2006	Consumer Alert: Use of Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) During First Trimester of Pregnancy Associated With Serious Birth Defects ACE inhibitors or ACEIs (short for angiotensin-converting enzyme inhibitors) used to treat high blood pressure can cause serious birth defects if taken during the first trimester of pregnancy.
July 13, 2006	Federal Judge Approves Settlement Over Baxter Infusion Pumps Baxter International Inc. and two of its top executives settled U.S. Justice Department allegations that two of its medication delivery pumps were flawed and violated federal law.
February 17, 2006	New Study Shows Women Using the Ortho Evra Birth-Control Patch Double Risk of Blood Clots Compared With Those Taking Birth-Control Pill Women using the Ortho Evra birth-control patch have twice the risk of developing blood clots than those who take the pill according to a new study funded by Ortho Women’s Health & Urology, the manufacturer of the patch.
October 2005	Paxil® Linked To Birth Defects and Congenital Malformations U.S. health officials and GlaxoSmithKline are warning doctors about the risk of major birth defects in infants born to women who take Paxil® during their first trimester of pregnancy.
August 10, 2005	Consumer Alert: F.D.A. Orders Class 1 Recall of Baxter International's Colleague Volumetric Infusion Pumps On July 21, 2005 the U.S. Food and Drug Administration took the unusual step of ordering a Class 1 Recall of Baxter International's Colleague Volumetric Infusion Pumps after receiving "hundreds of complaints" from various hospitals and patients.
June 20, 2005	Consumer Alert: Guidant Defibrillators Recalled On Friday, June 17, Guidant announced a recall of the Ventak Prizm 2 and additional model ICD's.
May 24, 2005	Consumer Alert: Guidant Ventak Prizm 2 Defibrillator According to news reports, the Guidant Ventak Implantable Cardioverter Defibrillator may have a flaw that could cause it to short-circuit and malfunction and cause injury or death. Approximately 24,000 of these devices have been implanted in persons world
April 27, 2005	Latest News on VIOXX Recall Robins, Kaplan, Miller & Ciresi L.L.P. is continuing to review claims related to the pain reliever VIOXX, which was withdrawn from the market on September 30, 2004 by Merck & Co., Inc. after a long-term clinical trial demonstrated an increased risk of heart attacks and strokes.
Friday, October 1, 2004	Vioxx Pulled Off the Market Because of Increased Risk of Heart Attack and Stroke The large drug manufacturer Merck &. Co., Inc. announced on September 30, 2004 that it would withdraw VIOXX (rofecoxib), its arthritis and acute pain medication, from the market world-wide.